| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Centro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Facultad de Ciencias, Campus de Cantoblanco, Madrid, Spain
Avila, Jesús, José J. Lucas, Mar Pérez, and Félix Hernández. Role of Tau Protein in Both Physiological and Pathological Conditions. Physiol Rev 84: 361–384, 2004; 10.1152/physrev.00024.2003.—The morphology of a neuron is determined by its cytoskeletal scaffolding. Thus proteins that associate with the principal cytoskeletal compo-nents such as the microtubules have a strong influence on both the morphology and physiology of neurons. Tau is a microtubule-associated protein that stabilizes neuronal microtubules under normal physiological conditions. However, in certain pathological situations, tau protein may undergo modifications, mainly through phosphorylation, that can result in the generation of aberrant aggregates that are toxic to neurons. This process occurs in a number of neurological disorders collectively known as tauopathies, the most commonly recognized of which is Alzheimer's disease. The purpose of this review is to define the role of tau protein under normal physiological conditions and to highlight the role of the protein in different tauopathies.
This article has been cited by other articles:
|
|
 |
|
  E. Planel, Y. Tatebayashi, T. Miyasaka, L. Liu, L. Wang, M. Herman, W. H. Yu, J. A. Luchsinger, B. Wadzinski, K. E. Duff, et al. Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms J. Neurosci., December 12, 2007; 27(50): 13635 - 13648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Goni-Oliver, J. J. Lucas, J. Avila, and F. Hernandez N-terminal Cleavage of GSK-3 by Calpain: A NEW FORM OF GSK-3 REGULATION J. Biol. Chem., August 3, 2007; 282(31): 22406 - 22413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Mehler and J. S. Mattick Noncoding RNAs and RNA Editing in Brain Development, Functional Diversification, and Neurological Disease Physiol Rev, July 1, 2007; 87(3): 799 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Marcantonio, J. L. Rudolph, D. Culley, G. Crosby, D. Alsop, and S. K. Inouye Review Article: Serum Biomarkers for Delirium J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1281 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Engel, F. Hernandez, J. Avila, and J. J. Lucas Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3. J. Neurosci., May 10, 2006; 26(19): 5083 - 5090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Cripps, S. N. Thomas, Y. Jeng, F. Yang, P. Davies, and A. J. Yang Alzheimer Disease-specific Conformation of Hyperphosphorylated Paired Helical Filament-Tau Is Polyubiquitinated through Lys-48, Lys-11, and Lys-6 Ubiquitin Conjugation J. Biol. Chem., April 21, 2006; 281(16): 10825 - 10838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Berger, B. Ravikumar, F. M. Menzies, L. G. Oroz, B. R. Underwood, M. N. Pangalos, I. Schmitt, U. Wullner, B. O. Evert, C. J. O'Kane, et al. Rapamycin alleviates toxicity of different aggregate-prone proteins Hum. Mol. Genet., February 1, 2006; 15(3): 433 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Carro, C. Spuch, J. L. Trejo, D. Antequera, and I. Torres-Aleman Choroid Plexus Megalin Is Involved in Neuroprotection by Serum Insulin-Like Growth Factor I J. Neurosci., November 23, 2005; 25(47): 10884 - 10893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Gallo, P. Jin, C. A. Thornton, H. Lin, J. Robertson, I. D'Souza, and W. W. Schlaepfer The Role of RNA and RNA Processing in Neurodegeneration J. Neurosci., November 9, 2005; 25(45): 10372 - 10375. [Full Text] [PDF]
|
|
|
|
 |
|
 A. P. Wasilewska-Sampaio, M. S. Silveira, O. Holub, R. Goecking, F. C. A. Gomes, V. M. Neto, R. Linden, S. T. Ferreira, and F. G. De Felice Neuritogenesis and neuronal differentiation promoted by 2,4-dinitrophenol, a novel anti-amyloidogenic compound FASEB J, October 1, 2005; 19(12): 1627 - 1636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lohi, L. Ianzano, X.-C. Zhao, E. M. Chan, J. Turnbull, S. W. Scherer, C. A. Ackerley, and B. A. Minassian Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy Hum. Mol. Genet., September 15, 2005; 14(18): 2727 - 2736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Williams, R. de Silva, D. C. Paviour, A. Pittman, H. C. Watt, L. Kilford, J. L. Holton, T. Revesz, and A. J. Lees Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism Brain, June 1, 2005; 128(6): 1247 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Shi, G. Zhao, D. Qiu, W. R. Godfrey, H. Vogel, T. A. Rando, H. Hu, and P. N. Kao NF90 Regulates Cell Cycle Exit and Terminal Myogenic Differentiation by Direct Binding to the 3'-Untranslated Region of MyoD and p21WAF1/CIP1 mRNAs J. Biol. Chem., May 13, 2005; 280(19): 18981 - 18989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. V. W. Johnson and W. H. Stoothoff Tau phosphorylation in neuronal cell function and dysfunction J. Cell Sci., November 15, 2004; 117(24): 5721 - 5729. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
